A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3-Reference-Cited by-同舟云学术

A Patient with Fulminant Myasthenia Gravis Is Seropositive for Both AChR and LRP4 Antibodies, Complicated by Autoimmune Polyglandular Syndrome Type 3

Author:

Inoue Hiroyasu¹²,Yamada Kentaro¹,Fujii Asami³,Tomonari Tatsuya⁴,Mizuno Kotaro⁵,Mita Keiko⁵,Higuchi Osamu⁶,Akao Masaya³,Matsukawa Noriyuki²

Affiliation:

1. Department of Neurology, Nagoya City East Medical Center, Japan

2. Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Japan

3. Department of Diabetes & Endocrinology, Nagoya City East Medical Center, Japan

4. Department of Nephrology, Nagoya City East Medical Center, Japan

5. Department of Surgery, Nagoya City East Medical Center, Japan

6. Department of Clinical Research, Nagasaki Kawatana Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

Reference23 articles.

2. 2. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14: 1023-1036, 2015.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Thiamazole;Reactions Weekly;2021-01